Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 17 studies | 64% ± 20% | |
oligodendrocyte precursor cell | 15 studies | 57% ± 19% | |
ciliated cell | 11 studies | 28% ± 8% | |
goblet cell | 8 studies | 57% ± 14% | |
respiratory goblet cell | 6 studies | 23% ± 7% | |
mucus secreting cell | 4 studies | 23% ± 4% | |
squamous epithelial cell | 3 studies | 41% ± 17% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 68% ± 20% | |
epithelial cell | 3 studies | 29% ± 11% | |
astrocyte | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 44305.94 | 2635 / 2642 | 91% | 62.76 | 645 / 705 |
prostate | 64% | 2745.32 | 157 / 245 | 96% | 34.60 | 484 / 502 |
stomach | 66% | 4772.57 | 237 / 359 | 71% | 16.81 | 204 / 286 |
intestine | 35% | 2610.63 | 340 / 966 | 74% | 20.48 | 391 / 527 |
bladder | 43% | 3138.52 | 9 / 21 | 65% | 25.59 | 326 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.77 | 1 / 1 |
pancreas | 0% | 0 | 0 / 328 | 81% | 32.81 | 145 / 178 |
breast | 8% | 278.05 | 39 / 459 | 65% | 19.87 | 724 / 1118 |
esophagus | 6% | 149.59 | 81 / 1445 | 41% | 14.05 | 75 / 183 |
lung | 2% | 39.85 | 9 / 578 | 36% | 8.62 | 412 / 1155 |
uterus | 1% | 12.52 | 1 / 170 | 25% | 5.93 | 117 / 459 |
lymph node | 0% | 0 | 0 / 0 | 24% | 7.81 | 7 / 29 |
tonsil | 0% | 0 | 0 / 0 | 18% | 3.38 | 8 / 45 |
peripheral blood | 8% | 276.79 | 70 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 6% | 0.81 | 26 / 406 |
kidney | 1% | 28.19 | 1 / 89 | 4% | 0.64 | 33 / 901 |
ovary | 1% | 21.18 | 1 / 180 | 1% | 0.13 | 6 / 430 |
skin | 0% | 8.53 | 4 / 1809 | 1% | 0.21 | 6 / 472 |
adipose | 1% | 27.01 | 13 / 1204 | 0% | 0 | 0 / 0 |
thymus | 0% | 7.14 | 1 / 653 | 0% | 0.01 | 1 / 605 |
blood vessel | 0% | 2.72 | 2 / 1335 | 0% | 0 | 0 / 0 |
heart | 0% | 9.82 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0042552 | Biological process | myelination |
GO_0005737 | Cellular component | cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
Gene name | BCAS1 |
Protein name | Brain enriched myelin associated protein 1 Brain enriched myelin associated protein 1 (cDNA FLJ50470, moderately similar to Rattus norvegicus breast carcinoma amplified sequence 1 (Bcas1), mRNA) (cDNA, FLJ78937, highly similar to Rattus norvegicus breast carcinoma amplified sequence 1 (Bcas1), mRNA) Breast carcinoma-amplified sequence 1 (Amplified and overexpressed in breast cancer) (Novel amplified in breast cancer 1) Brain enriched myelin associated protein 1 (cDNA FLJ50522, highly similar to Breast carcinoma amplified sequence 1) Breast carcinoma amplified sequence 1 BCAS1 protein Brain enriched myelin associated protein 1 (Breast carcinoma amplified sequence 1, isoform CRA_c) Brain enriched myelin associated protein 1 (Breast carcinoma amplified sequence 1, isoform CRA_b) |
Synonyms | hCG_37358 AIBC1 NABC1 |
Description | FUNCTION: Required for myelination. . |
Accessions | A0A8I5KX57 ENST00000422805.2 ENST00000686565.1 ENST00000371435.6 ENST00000685429.1 ENST00000689476.1 A0A8I5KRZ2 B4DHY3 Q05CL3 O75363 ENST00000690125.1 ENST00000688711.1 H0Y542 A0A8I5KUN3 H7C1E7 A0A8I5KSK1 B4DFL4 ENST00000688948.1 A0AVG7 ENST00000448484.5 G3XAF7 ENST00000395961.7 [O75363-1] |